1-(4-methoxyphenyl)piperazine
| Title | Journal |
|---|---|
| Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis. | Archives of toxicology 20161201 |
| Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action. | Neurotoxicology 20151201 |
| Piperazine compounds as drugs of abuse. | Drug and alcohol dependence 20120501 |
| Determination of piperazine-type stimulants in human urine by means of microextraction in packed sorbent and high performance liquid chromatography-diode array detection. | Journal of pharmaceutical and biomedical analysis 20120305 |
| 10α-Hy-droxy-13-{[4-(4-meth-oxy-phen-yl)piperazin-1-yl]meth-yl}-4,9-dimethyl-3,8,15-trioxatetra-cyclo-[10.3.0.0.0]penta-decan-14-one. | Acta crystallographica. Section E, Structure reports online 20120301 |
| Rapid determination of piperazine-type stimulants in human urine by microextraction in packed sorbent after method optimization using a multivariate approach. | Journal of chromatography. A 20120127 |
| Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry. | Journal of chromatography. A 20101001 |
| 4-(4-Methoxy-phen-yl)piperazin-1-ium chloride. | Acta crystallographica. Section E, Structure reports online 20090301 |
| The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. | European journal of pharmacology 20070322 |
| Metabolism of designer drugs of abuse. | Current drug metabolism 20050601 |
| In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. | Xenobiotica; the fate of foreign compounds in biological systems 20040201 |
| Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225 |
| Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. | Journal of mass spectrometry : JMS 20030601 |
| Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. | Forensic science international 20010915 |